Showing 1 - 10 of 685
Switching costs are a leading cause of customer lock-in in banking, reducing the extent of competition and increasing market power in this industry. This paper tries to estimate these costs using a methodology that does not require customer microdata. The estimates obtained here-using bank...
Persistent link: https://www.econbiz.de/10011866317
Persistent link: https://www.econbiz.de/10010228720
Persistent link: https://www.econbiz.de/10003550250
Persistent link: https://www.econbiz.de/10012251076
Persistent link: https://www.econbiz.de/10010489753
The aim of this study is to examine the level of market power of the Greek Small and Medium-sized Enterprises (SMEs) acting in the manufacturing and services industries respectively. This has been performed at a two digit level over the period 1970-2007, with the aim of investigating possible...
Persistent link: https://www.econbiz.de/10011620138
Crowdfunding has mostly been used to finance very unique projects. Recently, however, companies have begun using it to finance more traditional products where they compete against other sellers of similar products. Major crowdfunding platforms, Kickstarter and Indiegogo, as well as Amazon have...
Persistent link: https://www.econbiz.de/10012174171
This note investigates the possibility of profit raising entry in network industries where firms follow Corporate Social Responsibility (CSR) behaviours, showing the interaction between the network and CSR features. In particular, for high levels of the network effect, an incumbent’s profits...
Persistent link: https://www.econbiz.de/10011764906
The paper investigates firms’ behavior and outcomes (levels of cost-reducing R&D, output, profit and welfare in equilibrium) in a differentiated duopoly with process innovation. One of the important features in this paper is that spillovers operate in the R&D stage and are tied to the degree...
Persistent link: https://www.econbiz.de/10011885533
We analyze how a manufacturer with a brand-name drug close to patent expiration decides to launch a product-line extension (an upgrade through innovation) before it faces generic competition. There are two types of physicians: loyal physicians always prescribe first the product-line extension...
Persistent link: https://www.econbiz.de/10009355566